Publications Database

Moore M. L. , Eichner S. F. , Jones J. R. (2004)

Treating functional impairment of autism with selective serotonin-reuptake inhibitors.

Annals of Pharmacotherapy

38(9), pp. 1515-1519

Read Abstract (New Window)

Myers S. M. (2010)

Citalopram not effective for repetitive behaviour in autistic spectrum disorders.

Evidence Based Mental Health

13(1), pp. 22

Read Extract (New Window)

Myers S. M. (2007)

The status of pharmacotherapy for autism spectrum disorders.

Expert Opinion on Pharmacotherapy

8(11), pp. 1579-1603

Read Abstract (New Window)

Nadeau J. M. et al. (2011)

Treatment of comorbid anxiety and autism spectrum disorders.

Neuropsychiatry

December, 1(6), pp. 567-578.

Read Full (New Window)

Namerow L. et al. (2003)

Use of citalopram in pervasive developmental disorders.

Journal of Developmental and Behavioral Pediatrics

24(2), pp. 104-108

Read Abstract (New Window)

Owley T. et al. (2010)

A pharmacogenetic study of escitalopram in autism spectrum disorders.

Autism Research

3(1), pp. 1-7.

Read Abstract (New Window)

Owley T. et al. (2005)

An open-label trial of escitalopram in pervasive developmental disorders.

Journal of the American Academy of Child and Adolescent Psychiatry

44(4), pp. 343-348

Read Abstract (New Window)

Ozbayrak K. (1997)

Sertraline in PDD.

Journal of the American Academy of Child and Adolescent Psychiatry

36(1), pp. 7-8

Read Abstract (New Window)

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

American Society of Health-System Pharmacists (2009)

Citalopram.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2009)

Escitalopram.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2008)

Fluoxetine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2008)

Fluvoxamine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2009)

Paroxetine.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

American Society of Health-System Pharmacists (2008)

Sertraline.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Posey D. J. et al. (2006)

The use of selective serotonin reuptake inhibitors in autism and related disorders.

Journal of Child and Adolescent Psychopharmacology

16(1), pp. 181-186

Read Abstract (New Window)

Royal College of Psychiatrists (2015)

Antidepressants.

London: Royal College of Psychiatrists

Read Full (New Window)

Rajapakse T. , Pringsheim T. (2010)

Pharmacotherapeutics of tourette syndrome and stereotypies in autism.

Seminars in Pediatric Neurology

17(4), pp. 254-260

Read Abstract (New Window)

Rapp J. T. , Vollmer T. R. (2005)

Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods.

Research in Developmental Disabilities

26(6), pp. 548-564

Read Abstract (New Window)